122 related articles for article (PubMed ID: 38574959)
1. PD-1 and LAG-3 positive T cells are related with the prognosis of patients with chronic kidney disease.
Jiang H; Wu J; Zhang J
Exp Cell Res; 2024 May; 438(1):114027. PubMed ID: 38574959
[TBL] [Abstract][Full Text] [Related]
2. PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients.
Chen M; Zhu J; Yang X; Yao J; Liu Y; Liu Q
Eur J Med Res; 2022 Dec; 27(1):296. PubMed ID: 36529769
[TBL] [Abstract][Full Text] [Related]
3. CD4
Dong Y; Li X; Zhang L; Zhu Q; Chen C; Bao J; Chen Y
BMC Immunol; 2019 Aug; 20(1):27. PubMed ID: 31390978
[TBL] [Abstract][Full Text] [Related]
4. PD-1 has a unique capacity to inhibit allergen-specific human CD4
Rosskopf S; Jahn-Schmid B; Schmetterer KG; Zlabinger GJ; Steinberger P
Sci Rep; 2018 Sep; 8(1):13543. PubMed ID: 30201974
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of PD-1 and LAG-3 in the exhaustion of CD4
Okagawa T; Konnai S; Nishimori A; Maekawa N; Goto S; Ikebuchi R; Kohara J; Suzuki Y; Yamada S; Kato Y; Murata S; Ohashi K
Vet Res; 2018 Jun; 49(1):50. PubMed ID: 29914540
[TBL] [Abstract][Full Text] [Related]
6. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
Front Immunol; 2020; 11():576743. PubMed ID: 33519801
[TBL] [Abstract][Full Text] [Related]
7. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Matsuzaki J; Gnjatic S; Mhawech-Fauceglia P; Beck A; Miller A; Tsuji T; Eppolito C; Qian F; Lele S; Shrikant P; Old LJ; Odunsi K
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7875-80. PubMed ID: 20385810
[TBL] [Abstract][Full Text] [Related]
9. PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Zelba H; Bedke J; Hennenlotter J; Mostböck S; Zettl M; Zichner T; Chandran A; Stenzl A; Rammensee HG; Gouttefangeas C
Cancer Immunol Res; 2019 Nov; 7(11):1891-1899. PubMed ID: 31484656
[TBL] [Abstract][Full Text] [Related]
10. Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.
Ye J; Liu Q; Fu Q; Li B; Huang J; Zeng G
J Coll Physicians Surg Pak; 2023 Apr; 33(4):421-426. PubMed ID: 37190715
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of LAG-3, but not PD-1, on double negative T cells at the female genital tract.
Juno JA; Lajoie J; Stalker AT; Oyugi J; Kimani M; Kimani J; Plummer FA; Fowke KR
Am J Reprod Immunol; 2014 Dec; 72(6):534-40. PubMed ID: 25154740
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
13. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
15. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
He Y; Yu H; Rozeboom L; Rivard CJ; Ellison K; Dziadziuszko R; Suda K; Ren S; Wu C; Hou L; Zhou C; Hirsch FR
J Thorac Oncol; 2017 May; 12(5):814-823. PubMed ID: 28132868
[TBL] [Abstract][Full Text] [Related]
16. [Expression levels of co-inhibitory molecules CTLA-4, LAG-3, PD-1 and CD39 on CD4⁺ T cells correlate with progression of non-small cell lung cancer].
Wei T; Zhang J; Wu Y; Zhang D; Lu L; Shen Q
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):424-9. PubMed ID: 25241783
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.
Okagawa T; Konnai S; Deringer JR; Ueti MW; Scoles GA; Murata S; Ohashi K; Brown WC
Infect Immun; 2016 Oct; 84(10):2779-90. PubMed ID: 27430272
[TBL] [Abstract][Full Text] [Related]
19. Correlation of increased Th17/Treg cell ratio with endoplasmic reticulum stress in chronic kidney disease.
Zhu X; Li S; Zhang Q; Zhu D; Xu Y; Zhang P; Han J; Duan Z; Gao J; Ou Y
Medicine (Baltimore); 2018 May; 97(20):e10748. PubMed ID: 29768353
[TBL] [Abstract][Full Text] [Related]
20. Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells.
Ma J; Yan S; Zhao Y; Yan H; Zhang Q; Li X
Front Immunol; 2023; 14():1265255. PubMed ID: 37841254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
